DMP1 as a drug target for bone diseases

TECH FIELD(S)
Medical- Therapeutics

FEATURES
We have discovered and validated dentin matrix protein-1 (DMP-1) as a target for bone formation. Either agonists or antagonists could be engineered based on this target or fragments of the target protein to treat disorders by regulating bone mineral density.

BENEFITS
* Improves bone formation over control

Inventor(s): Dr. Kenneth White

Type of Offer: Licensing



« More Medical Patents

---